Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP138685.RARGHHdOrlYwDH1Kr2xmI0apdB_l9WBJPtd1DgcwxOlK4130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138685.RARGHHdOrlYwDH1Kr2xmI0apdB_l9WBJPtd1DgcwxOlK4130_provenance.
• NP138834.RAWFbLGpIL5kW4Chne82eGTB267P_iu7v9tYgZtZXel0w130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138834.RAWFbLGpIL5kW4Chne82eGTB267P_iu7v9tYgZtZXel0w130_provenance.
• NP137187.RAkiGsqlp0fSRKJPMGeT7JjdEiC6GkuCKzU2AKMEzWAtE130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137187.RAkiGsqlp0fSRKJPMGeT7JjdEiC6GkuCKzU2AKMEzWAtE130_provenance.
• NP137282.RAlfLJgR8BRnHghfJbuLE2uyMWp01gErpHPhEbdn-OmTQ130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137282.RAlfLJgR8BRnHghfJbuLE2uyMWp01gErpHPhEbdn-OmTQ130_provenance.
• NP138726.RAnC0doqHzMJNwX-m8IIrJsZ9Ihyf-Qsxu1f1T-FFhLBo130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138726.RAnC0doqHzMJNwX-m8IIrJsZ9Ihyf-Qsxu1f1T-FFhLBo130_provenance.
• NP138738.RAi1s19-GUMsQ9lA-ZcCtX8mxQLnCGbMLS_4-XVJ7ZQVE130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138738.RAi1s19-GUMsQ9lA-ZcCtX8mxQLnCGbMLS_4-XVJ7ZQVE130_provenance.
• NP73671.RAaJvIt4WiLI2kr3-TBmuU7K3rs_-Gh81JHJ5laIOm18Q130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73671.RAaJvIt4WiLI2kr3-TBmuU7K3rs_-Gh81JHJ5laIOm18Q130_provenance.
• NP73674.RAecEQQLzoKXy7Epz9MwJOJcax-U0x5nj8FUkX5viRq6U130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73674.RAecEQQLzoKXy7Epz9MwJOJcax-U0x5nj8FUkX5viRq6U130_provenance.
• NP73676.RAajtww40liEePPyB7LvDSHlUnIs9Gs9UHUPBQTgZ22m8130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73676.RAajtww40liEePPyB7LvDSHlUnIs9Gs9UHUPBQTgZ22m8130_provenance.
• NP73679.RAYCrmaeuPRHXOjYZMIc2ZFrboXaM-w1lwqoYRT9sbFQA130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73679.RAYCrmaeuPRHXOjYZMIc2ZFrboXaM-w1lwqoYRT9sbFQA130_provenance.
• NP73672.RAq1O8gYPjiIMLV9Lepgk8VQV2nR2wCyFVY3xSs7clLK4130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73672.RAq1O8gYPjiIMLV9Lepgk8VQV2nR2wCyFVY3xSs7clLK4130_provenance.
• NP73673.RAtcZNVjdMAYwLmeXvgoWRl6QqQrCDrlahaatDnITwJ8I130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73673.RAtcZNVjdMAYwLmeXvgoWRl6QqQrCDrlahaatDnITwJ8I130_provenance.
• NP73678.RAqawjwLhPER8rEFx_FcQTaBrP84hui_I5O7pDsZe2GGM130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73678.RAqawjwLhPER8rEFx_FcQTaBrP84hui_I5O7pDsZe2GGM130_provenance.
• NP138683.RAybmqxXhXY2UsC3Xv2sWE8zmFgWnafYHFccy4yT-Bp-A130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138683.RAybmqxXhXY2UsC3Xv2sWE8zmFgWnafYHFccy4yT-Bp-A130_provenance.
• NP138831.RA_RZNJUk5x1w2iC0oW-Em0aIsnOxX5dbfIDtRTtIRe68130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138831.RA_RZNJUk5x1w2iC0oW-Em0aIsnOxX5dbfIDtRTtIRe68130_provenance.
• NP138732.RAIximtzN-rFJGuttWDOCzTScCZF8MmTA5RUie04sjtgQ130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138732.RAIximtzN-rFJGuttWDOCzTScCZF8MmTA5RUie04sjtgQ130_provenance.
• NP73675.RAKAf0hEqhGGAHwechL8V08vemE-6aoAKGdbFPgsL9APQ130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73675.RAKAf0hEqhGGAHwechL8V08vemE-6aoAKGdbFPgsL9APQ130_provenance.
• NP73677.RA4xsZEzo2plbgjF2NoMxQ7spt5JRY4C8kZsrXpBr9slM130_assertion description "[Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73677.RA4xsZEzo2plbgjF2NoMxQ7spt5JRY4C8kZsrXpBr9slM130_provenance.